Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?
epidemiology
pancreatic neuroendocrine neoplasms
sex
sex difference
Journal
Trends in endocrinology and metabolism: TEM
ISSN: 1879-3061
Titre abrégé: Trends Endocrinol Metab
Pays: United States
ID NLM: 9001516
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
12
11
2019
revised:
19
02
2020
accepted:
21
02
2020
pubmed:
1
4
2020
medline:
10
8
2021
entrez:
1
4
2020
Statut:
ppublish
Résumé
Genetic and molecular disparities between men and women have a role in the differing incidence, pathophysiology, clinical signs, and treatment outcome of several cancers. Sex differences in cancer incidence are attributed to regulation at the genetic/molecular level and to sex hormones that in turn modulate gene expression in various cancers. Sex differences in the incidence of cancer, its aggressiveness, and the disease prognosis have been reported for several types of cancer but little is known for pancreatic neuroendocrine neoplasms (PNENs). The aim of this Opinion article is to provide an overview of sex differences in PNENs in terms of epidemiology, pathophysiology, treatment responses, prognosis, and survival. This overview might allow better tailoring of the management of PNENs.
Identifiants
pubmed: 32223919
pii: S1043-2760(20)30052-7
doi: 10.1016/j.tem.2020.02.010
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
631-641Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.